NL-OMON20761已完成不适用
Study on chronic hepatitis Ctreatment with interferon alpha, ribavirin and amantadine in naive patients.
Dr. K.J. van Erpecum, hoofdonderzoekerProf. Dr. M. Samsom, hoofdonderzokerUMC UtrechtHuispostnummer F02.618Postbus 855003508 GA Utrecht0 个研究点目标入组 390 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 390
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Anti-HCV positivity; >6 months;
- •2. ALT and/or AST elevation on at least once in the previous 6 months;
排除标准
- •1. Age < 18 years;
- •2. Pregnancy or intention to get pregnant within the 12 months period of treatment and up to 6 months after discontinuation of therapy, no adequate contraception, lactation;
研究者
相似试验
已完成
不适用
Study on chronic hepatitis C treatment with interferon alpha, ribavirin and amantadine in naive patients.Chronic viral hepatitisInfections and InfestationsHepatitis CISRCTN74271466niversity Medical Centre Utrecht (UMCU) (Netherlands)390
已完成
不适用
Retreatment of chronic hepatitis C patients with pegylated interferon, ribavirin and amantadine; A pilot study to establishif initial drop in viral load is predictive for sustained virological response.Chronic hepatitis C infectionNL-OMON27702Schering-Plough61
已完成
2 期
Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816Chronic Hepatitis CNCT02468648National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)72
招募中
不适用
Functional Cure of Hepatitis B in HIV/HBV Co-infected PatientsAIDSHepatitis BNCT05988879Guangzhou 8th People's Hospital60
已完成
不适用
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsInterferonHepatitis BNCT03546530The First Hospital of Jilin University228